ArthroCare Corp. (NASDAQ: ARTC) announced today that it has been
informed by the SEC’s Fort Worth District
Office that the Staff of the SEC's Division of Enforcement is conducting
an informal inquiry into accounting matters related to ArthroCare
Corporation arising out of the Company's recently announced restatement
of financial results. The Company stated that it will cooperate fully
with the SEC.
About ArthroCare
Founded in 1993, ArthroCare Corp. (www.arthrocare.com)
is a highly innovative, multi-business medical device company that
develops, manufactures and markets minimally invasive surgical products.
With these products, ArthroCare targets a multi-billion dollar market
opportunity across several medical specialties, significantly improving
existing surgical procedures and enabling new, minimally invasive
procedures. Many of ArthroCare’s products are
based on its patented Coblation technology, which uses low-temperature
radiofrequency energy to gently and precisely dissolve rather than burn
soft tissue - minimizing damage to healthy tissue. Used in more than
four million surgeries worldwide, Coblation-based devices have been
developed and marketed for sports medicine; spine/neurologic; ear, nose
and throat (ENT); cosmetic; urologic and gynecologic procedures.